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Reply to the Editor:
There is no doubt that psychosocial issues
and social support systems are appropriate
considerations when evaluating potential
transplant recipients. Considering social
worth, on the other hand, is not justifiable.
I have read that the California prisoner in
the news stories died within a year after his
transplant, in part due to noncompliance.
That would not surprise Dr Richenbacher,
of course, in light of his comments.
But I wonder if we can make a blanket
assumption that no prisoner can be compli-
ant or that every prisoner cannot be ade-
quately available for postoperative fol-
low-up visits. Would not individual
consideration be warranted? Nelson Man-
dela may not be unique as a prisoner who
could be seriously considered for listing.
The status of prisoner, per se, should not
preclude consideration for transplantation,
in my view.
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Reply to the Editor:
I thank Dr Richenbacher for his thoughtful
letter. In an earlier, more naı¨ve version of
my life, I served as the surgeon at Minne-
sota’s maximum-security prison, a rotation
for University residents during the tenure
of the imaginative Owen Wangensteen. I
had a very positive experience with the
staff I worked with in the OR; they had
learned to be nurse anesthetists and radio-
logic or surgical technicians while serving
life sentences for crimes of passion against
unfaithful spouses or their consorts. I asked
their advice about whether prisoners should
be considered as possible altruistic kidney
donors. Then, as a resident member of the
transplant advisory committee, I advocated
allowing prisoners to donate kidneys as
good Samaritans. It worked beautifully, un-
til one day a paroled donor blackmailed the
recipient, threatening to take his kidney
back! I still advocate individual rather than
categorical judgments, so I support the
view that we shouldn’t accept or exclude
all prisoners from the complex social and
medical transaction of organ transplanta-
tion. However, the outcome of the Califor-
nia prisoner transplant described in Dr
Sade’s response and my youthful Minne-
sota experience argue for cautious conser-
vatism.
Martin McKneally, MD, PhD
University of Toronto
Department of Surgery
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Indications for pulmonary
endarterectomy
To the Editor:
The recent article by Thistlethwaite and
colleagues1 could confuse nonsurgeons
caring for patients with chronic thrombo-
embolic pulmonary hypertension,2 espe-
cially if they become optimistic about pul-
monary endarterectomy after reading many
articles on the pioneering work from the
San Diego group.
Thistlethwaite and colleagues state
that the selection criteria for endarterec-
tomy included New York Heart Associa-
tion (NYHA) classes III and IV. Never-
theless, according to Table 1, 71 of 202
patients (35.1%) were in NYHA class I
or II! This deserves explanation. I would
never subject asymptomatic or very
lightly symptomatic patients to this type
of surgery, which carries considerable
morbidity and mortality. The same holds
true for patients with pulmonary vascular
resistance below 4 Wood units (320 dyn
· s · cm5).
In the 76 patients from group 1, the
surgeon found fresh (acute) thrombus in
the main lobar pulmonary arteries. In most
instances, fresh thrombus undergoes spon-
taneous lysis in anticoagulated patients; if
needed this resolution can be accelerated
by therapeutic thrombolysis. Simple embo-
lectomy, if ever, would be the appropriate
surgical intervention instead of endarterec-
tomy. Did these patients have chronic
thromboembolic pulmonary hypertension
at all? Were all of them treated with anti-
coagulants for at least 3 months? In pa-
tients adequately anticoagulated for 3
months, the presence of fresh thrombus in
their pulmonary arteries must be an abso-
lute rarity.3 The low operative mortality in
this group does not alone entitle the sur-
geon to operate; most probably the long-
term prognosis of these patients would be
just as good or better without surgery and
with anticoagulation alone.2
On the other extreme of the patient
spectrum, there are 7 patients (group 4)
with microscopic distal arterial vasculopa-
thy but without apparent thromboembo-
lism. In my opinion, this could be easily
identified by pulmonary angiography and
scintigraphy, and these patients should not
be subjected to endarterectomy.3 Why
were they operated on? The same probably
applies to patients with disease limited to
segmental arteries (group 3); even if end-
arterectomy can be achieved in these ves-
sels (each segment making up only about
5% of the cross-sectional area of the pul-
monary vascular bed), many segmental ar-
teries must be operated on to get a clini-
cally relevant result, making the operation
very demanding and risky.
Table 4 on perioperative mortality does
not correspond to the 1-month survival data
in Table 3. Probably morbidity instead of
mortality is described in Table 4; neverthe-
less, the table makes clear that there are
frequent and considerable complications of
the procedure, which underlies the neces-
sity to restrict endarterectomy only to pa-
tients who really need it and who might
benefit from it.
Benevolent indications for surgery re-
sult in great numbers of operated-on pa-
tients, often with statistically good results
(probably due in part to operations on less
sick patients) but with the dangers of un-
necessary morbidity and mortality just in
those less sick individuals. We cardiolo-
gists know this all too well from coronary
angioplasties and stent implantations. Be-
nevolent indications tend to discredit the
procedure so that it will not be offered to
patients who might really benefit from it.
Unless well-documented prospective stud-
ies persuade me otherwise, I will continue
to restrict the indication to pulmonary end-
arterectomy to severely limited patients
(NYHA class III or IV) without evidence
of improvement after 6 months of adequate
anticoagulation, who have a resting pulmo-
nary vascular resistance of more than 4
Wood units, resting mean pulmonary artery
pressure greater than 30 mm Hg, and bilat-
eral central (lobar and proximal) surgically
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